… Pharmaceuticals. What Are The Emerging Trends In The Artery Stenosis Drug … address unmet medical needs in the treatment of … Aspirin, Clopidogrel, Ticagrelor, Prasugrel, Dipyridamole 2 By … Anticoagulants DOACs 3 By Statins: Atorvastatin, Simvastatin, …

… /Late-Breaking Trials: Major Late-Breaking Trials from EuroPCR 2025 Presentation … followed by dose reduction of prasugrel after drug-coated stent insertion in … Research Randomized controlled/clinical trial Subject of Research People Article …

… coronary syndrome (ACS) to prasugrel monotherapy after one month of … year. Gachon University Gil Medical Center announced Tuesday that the … prasugrel monotherapy at a reduced dose: the 4D-ACS randomized trial … Top 3 Late Breaking Trials at the 2025 European …

… and prasugrel are medications … statins Non-statins are cholesterol-lowering medications that doctors may prescribe in addition to statins … doctor about possible drug-drug interactions, especially if they are taking other medications. A doctor … The treatment for …

… the 4D-ACS trial – one-month DAPT followed by prasugrel 5 mg … PCI with a biolimus-coated drug-eluting stent, the BioFreedomTM Ultra … was ethnically similar and further trials would need to study the …

… clopidogrel, as well as prasugrel and ticagrelor, which are newer … where cangrelor has been introduced. Treatment acquisition, clinical event, and … nice.org.uk/drug/;tirofiban.html. Accessed February … https://www.medicines.org.uk/emc/ …

… the first 50 TIMI trials. The Baim institute was … Journal of Medicine) and have led 70 FDA submissions from … in international approval of drugs like prasugrel, rivaroxaban, betrixaban and … which improves the way active pharmaceutical ingredients (APIs) enter …

… when someone comes to the doctor after a previous heart or … and prasugrel, in a phase 3 trial.  After phase 3, the drug gets … the results from the American trials had to do with … aspirin dosing.  Thomas Marciniak, an FDA medical officer who reviewed this second …

… established in the treatment of acute coronary … like clopidogrel and prasugrel. While AstraZeneca, … FDA medical officer with an atypical reputation for thorough reviews of drug … trial “has no reason to be challenged,” but argues that subsequent trials …

… the landmark trial that launched the antiplatelet drug ticagrelor worldwide … by some FDA staff members, including medical officer Thomas … such as clopidogrel and prasugrel. "Critics said … readjudicating in the current treatment era." Other calls …